Risk & Weakness
Thomas Insolvency Candidate
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 8 hits from US
Looks for companies with high bankruptcy risk: weak balance sheet (at least 2 warning signs), earnings don't cover interest, low Altman score, plus falling revenue AND falling earnings per share versus the year-ago quarter. The market has to confirm the weakness too: no Weinstein Stage 2 (i.e. no established uptrend) and a stress-day relative strength below 80 points. Stocks whose most recent Börsenlotse deep-dive ends on a yellow traffic light (no clear verdict) are excluded — only an unambiguous picture counts here. Banks, insurers, and biotech are excluded.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Fundamental Rating ≥ 55 out of 100) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(16)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Altman Z-Score
- A bankruptcy early-warning system developed by Edward Altman: several balance-sheet ratios are combined into one score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. Values from 2.6 up are considered a safe zone, values below 1.1 a distress zone with elevated bankruptcy risk; in between lies a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SABR Sabre Corporation | 08/06 | -15 % | 73 7/25 | Stage 3 | C 46 | 4 of 9 | 0.8 $ | Software - Infrastructure | Sells AI | — | Technology | 1.90 $ | +28.7 % | +47.2 % | -38.9 % | −46.9 % | +4.7 % | 36 | 6 | 9.0 % | 7.4 % | 0.96 | — | 37.7 | 0.3 | 147.4 | — | 1.68 | 12.7 | — | 56.5 % | 17.6 % | -737.4 % | 5.1 % | -4.10 | — | -8.5 % | 4 | 0.0 % | 0.0 % | 0.0 | 90.2 % | 11.0 % | 3.7 (7) | |
| LFCR Lifecore Biomedical Inc. | — | -12 % | 29 3/22 | Stage 4 | D 35 | 4 of 9 | 0.2 $ | Drug Manufacturers - Specialty & Generic | Neutral | — | — | Healthcare | 4.40 $ | -30.8 % | -39.9 % | -36.9 % | −40.0 % | +26.8 % | 34 | 42 | 5.7 % | 5.8 % | 1.06 | — | 6.8 | 1.3 | 161.6 | 65.6 | 2.66 | 25.0 | — | 31.4 % | -23.8 % | -76.4 % | -3.0 % | 7.23 | — | +0.5 % | — | 0.0 % | 0.0 % | 0.9 | 77.2 % | 7.8 % | — |
| PESI Perma-Fix Environmental Svcs Inc | 08/06 | 0 % | 37 5/29 | Stage 4 | D 30 | 3 of 9 | 0.3 $ | Waste Management | Neutral | — | — | Industrials | 16.60 $ | -11.9 % | +3.6 % | +44.1 % | −25.8 % | +50.6 % | 34 | 15 | 7.2 % | 7.1 % | 0.45 | — | 99.0 | 5.9 | — | — | — | -31.4 | — | 4.1 % | -30.1 % | -28.5 % | -11.1 % | — | — | +4.3 % | — | 0.0 % | 0.0 % | -1.0 | 49.3 % | 11.7 % | 5.0 (1) |
| BAER Bridger Aerospace Group Holdings, Inc. Common Stock | 08/06 | -24 % | 18 3/29 | Stage 1 | D 37 | 2 of 9 | 0.1 $ | Security & Protection Services | – | — | — | Industrials | 1.90 $ | -5.5 % | +5.9 % | +12.8 % | −51.7 % | +148.0 % | 30 | 66 | 5.7 % | 7.2 % | 0.36 | — | 11.0 | 1.0 | — | — | — | 28.3 | — | 38.6 % | -10.1 % | -31.6 % | 0.1 % | — | — | +24.6 % | 6 | 0.0 % | 0.0 % | -1.2 | 40.5 % | 4.7 % | — |
| CSR Centerspace | 08/03 | +4 % | 63 5/21 | Stage 1 | D 31 | 2 of 9 | 1.0 $ | REIT - Residential | – | — | — | Real Estate | 54.80 $ | -14.3 % | -13.0 % | +6.1 % | −18.5 % | +19.0 % | 29 | 42 | 3.1 % | 3.4 % | 0.92 | 118.2 | 55.6 | 3.6 | 1.3 | 13.8 | 40.89 | 11.3 | — | 58.9 % | 3.1 % | 1.4 % | 0.8 % | 1.45 | — | +35.3 % | 4 | 5.6 % | 655.3 % | 2.3 | 94.8 % | 5.3 % | 3.7 (12) |
| SVC Service Properties Trust | 08/04 | -25 % | 31 3/21 | Stage 4 | D 36 | 3 of 9 | 1.0 $ | REIT - Hotel & Motel | – | — | — | Real Estate | 8.00 $ | -6.0 % | -1.2 % | -37.6 % | −44.7 % | +52.3 % | 16 | 10 | 5.0 % | 4.8 % | 1.63 | — | 21.4 | 0.6 | — | 27.1 | 2.27 | 14.5 | — | 31.0 % | -13.6 % | -38.6 % | 1.9 % | — | — | -4.3 % | 4 | 2.5 % | 466.7 % | 0.9 | 47.2 % | 3.5 % | 3.7 (3) |
| NOG Northern Oil & Gas Inc | 07/30 | -10 % | 56 2/10 | Stage 1 | D 36 | 3 of 9 | 2.4 $ | Oil & Gas E&P | – | — | — | Energy | 21.20 $ | -8.2 % | -14.2 % | -19.0 % | −36.9 % | +45.7 % | 12 | 21 | 4.1 % | 3.9 % | 0.71 | — | 5.7 | 1.1 | 1.3 | — | 5.69 | 30.3 | -73.6 % | 74.6 % | -32.4 % | -29.8 % | 4.3 % | 1.43 | 32.4 % | -3.2 % | 3 | 8.5 % | 69.2 % | 2.4 | 107.0 % | 21.1 % | 3.8 (9) |
| AKBA Akebia Therapeutics, Inc. | 08/06 | +3 % | 29 3/22 | Stage 4 | D 32 | 1 of 9 | 0.3 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 1.30 $ | -31.7 % | -34.7 % | -64.2 % | −74.5 % | +223.1 % | 5 | 42 | 7.0 % | 7.4 % | 0.24 | — | 28.7 | 1.5 | 14.0 | 5.7 | — | 66.9 | — | 81.9 % | -8.8 % | -79.0 % | 2.0 % | 0.46 | — | +47.5 % | — | 0.0 % | 0.0 % | -10.8 | 42.1 % | 7.2 % | 4.8 (4) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Looks for companies with high bankruptcy risk: weak balance sheet (at least 2 warning signs), earnings don't cover interest, low Altman score, plus falling revenue AND falling earnings per share versus the year-ago quarter. The market has to confirm the weakness too: no Weinstein Stage 2 (i.e. no established uptrend) and a stress-day relative strength below 80 points.
All scanners are recalculated daily across the entire stock universe — most recently on 3. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 8 stocks pass this scanner's criteria (as of 3. August 2026).
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Fundamental Rating ≥ 55 out of 100) are excluded.
This scanner deliberately hunts for red flags — a hit is a finding, not a recommendation: like a smoke detector that beeps so you look in time. A hit is also not a bankruptcy verdict; most companies save themselves (say, through a capital raise, which dilutes existing shareholders). Portfolio owners use the list as an early-warning system, bargain hunters as an anti-shopping list, experienced traders as a watch list — it is never a buy or short recommendation.
Related scanners
- Altman Z: Distress Zone
- Bankruptcy Study: Stacked Warning Signals
- Below the 50- & 200-SMA
- Beneish M-Score
- Downward Momentum
- Going Concern (Distress Proxy)
- Insolvency Radar: Cash Running Low
- Kathy Donnelly: Liquid Movers Down
- Mike Webster: Overextended (Webby RSI)
- Near 52-Week Low
- Pradeep Bonde: $ Breakout Bearish
- Pradeep Bonde: 4% Breakout Bearish
- Qullamaggie: Parabolic (Short-Watch)
- RS Weakness (≤10)
- Stage 4 (Downtrend)
- Stan Weinstein: Stage 4
- Stan Weinstein: Stage 4B-
- Weakness Cluster
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.